Industry

OSAKA, Japan–(BUSINESS WIRE)–#medical–Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medical Limited (Headquarters: Osaka, Japan; President: Shojiro Matsuda) and HistoSonics, Inc. (Headquarters: Minneapolis, MN USA; CEO: Mike Blue) have entered into an agreement to exclusively distribute a noninvasive platform and proprietary sonic beam therapy … [Read more…]

New facility will expand accessibility for HIV/AIDS specialty services, free STI/STD prevention and treatment services, primary medical care and access to non-profit pharmacy services Ribbon-cutting ceremony with local dignitaries scheduled for Wednesday, October 8, 2025, at 10:30am at 4299 Elvis Presley Boulevard, Memphis, TN. Current statistics indicate Memphis, nationally, ranks 2nd in new HIV diagnosis, … [Read more…]

Funding and product launch advance company’s efforts to make high-quality, affordable healthcare accessible to all Americans NEW YORK–(BUSINESS WIRE)–Nava Benefits today announced the launch of HQ, the industry’s first AI-powered benefits platform built to eliminate benefits busy work for HR teams, deliver a powerful renewal experience that unifies quoting, benchmarking and demographics, and gives HR … [Read more…]

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of November 11, 2025, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. … [Read more…]

-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today presented non-clinical data demonstrating the ability of its proprietary JUST-AAV capsid … [Read more…]

BOSTON–(BUSINESS WIRE)–#AASLD–nChroma Bio (“nChroma”), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, today announced the acceptance of three abstracts, including a poster of distinction, at the upcoming AASLD Liver Meeting®, taking place November 7 to 11, 2025, in Washington, D.C. “At AASLD, we’re showcasing the … [Read more…]

First evaluation of benefit-to-burden for new screening options using methodologies adopted by the United States Preventive Services Task Force Noninvasive test performance is critical to support patient outcomes and reduce burden on limited colonoscopy capacity MADISON, Wis.–(BUSINESS WIRE)–Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests today announced the publication … [Read more…]

TOKYO–(BUSINESS WIRE)–RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has conducted a Phase 2 clinical trial of umedaptanib pegol (anti-FGF2 aptamer) in pediatric patients (ages 5-14) with achondroplasia (ACH). The company announced today that the administration of the high-dose (0.6 mg/kg) subcutaneous injection (once biweekly) group (Cohort 2 Note 1) has completed … [Read more…]

U.S. News Honor Roll of Best Children’s Hospitals distinguishes CHLA with six specialties ranking in top 10 in the nation LOS ANGELES–(BUSINESS WIRE)–As a leader in pediatric academic medicine for nearly 125 years, Children’s Hospital Los Angeles (CHLA) continues to fulfill its mission by advancing care and making discoveries that enhance and save lives. Today, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Stability Testing of Pharmaceuticals and Biopharmaceuticals Training Course (Nov 10th – Nov 11th, 2025)” training has been added to ResearchAndMarkets.com’s offering. By attending this intensive two-day seminar, delegates will learn how to: Carry out appropriate stability studies and manage stability samples and facilities Design stability studies that are suitable for global marketing Increase … [Read more…]